Twist Bioscience Corp (TWST)
137.64
+3.20 +2.38%
NASDAQ
Feb 26, 20:00
USD
View All Key Stats
Key Stats
Income Statement | |
Revenue (TTM) | 101.10M |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (TTM) | -2.78 |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Net Income (TTM) | -117.19M |
Profitability | |
Gross Profit Margin (Quarterly) | 35.51% |
Profit Margin (Quarterly) | -116.8% |
Dividend | |
Dividend Yield (Forward) | Upgrade |
Dividend Yield | 0.00% |
Price and Valuation | |
Market Cap | 6.696B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
PS Ratio | 57.65 |
PE Ratio | -- |
Price to Book Value | 10.50 |
Other | |
Beta (5Y) | Upgrade |
Debt to Equity Ratio | 0.0062 |
Free Cash Flow (Quarterly) | -28.56M |
Return on Equity | Upgrade |
View All TWST News
News
-
WireHeadlineTime (ET)
-
Yahoo02/24 11:06
-
SA Breaking News02/24 08:42
-
Yahoo02/24 08:00
-
Yahoo02/24 04:36
-
Yahoo02/22 05:00
-
Yahoo02/19 08:00
-
Yahoo02/18 09:00
-
MT Newswires02/10 12:19
-
SA Breaking News02/05 12:39
-
Yahoo02/05 11:33
-
Yahoo02/05 11:09
-
SA Breaking News02/05 11:01
-
SA Breaking News02/05 08:34
-
SA Breaking News02/05 07:46
-
MT Newswires02/05 06:53
-
Yahoo02/05 00:01
-
Yahoo02/04 18:05
-
SA Breaking News02/04 17:52
-
MT Newswires02/04 17:20
-
Yahoo02/04 17:06
View All Events
Events
Date | Type | Description |
---|---|---|
05/07/2021 | Earnings | Twist Bioscience Corp Second Quarter Earnings Results for 2021 |
05/07/2021 | Misc | Twist Bioscience Corp Second Quarter Earnings Conference Call for 2021 |
02/04/2021 | Earnings | Twist Bioscience Corp First Quarter Earnings Result for 2021 |
02/04/2021 16:30 EST | Misc | Twist Bioscience Corp First Quarter Earnings Conference Call for 2021 |
02/03/2021 08:00 PST | Misc | Twist Bioscience Corp Annual General Meeting for 2020 |
11/27/2020 | Misc | Twist Bioscience Corp Annual Report for 2020 |
11/23/2020 | Earnings | Twist Bioscience Corp Fourth Quarter Earnings Result for 2020 |
11/23/2020 08:00 EST | Misc | Twist Bioscience Corp Fourth Quarter Earnings Conference Call for 2020 |
08/06/2020 16:30 EDT | Misc | Twist Bioscience Corp Third Quarter Earnings Conference Call for 2020 |
08/06/2020 | Earnings | Twist Bioscience Corp Third Quarter Earnings Result for 2020 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.twistbioscience.com
- Investor Relations URL: N/A
- HQ State/Province: California
- Sector: Healthcare
- Industry: Diagnostics & Research
- Equity Style: Mid Cap/Growth
- Next Earnings Release: May. 07, 2021
- Last Earnings Release: Feb. 04, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Analyst Coverage
Consensus Recommendations | |
Buy Recommendations | Upgrade |
Outperform Recommendations | Upgrade |
Hold Recommendations | Upgrade |
Underperform Recommendations | Upgrade |
Sell Recommendations | Upgrade |
Consensus Recommendation | Upgrade |
Consensus Rating | Upgrade |
Target Price | |
Price | 137.64 |
Price Target | Upgrade |
Price Target Upside (Daily) | Upgrade |
Top Fund Holders
Symbol | Name | Weighting |
---|---|---|
ARKG | ARK Genomic Revolution ETF | 5.61% |
EAGB.NO | Emerge ARK Genomics & Biotech ETF | 5.59% |
PTH | Invesco DWA Healthcare Momentum ETF | 3.90% |
IDNA | iShares Genomics Immnlgy & Hlthcr ETF | 3.46% |
EARK.NO | Emerge ARK Global Disruptive Innovt ETF | 2.12% |
ARKK | ARK Innovation ETF | 2.10% |
DBMCX | BNY Mellon Sm/Md Cp Gr C | 1.87% |
GTSDX | Invesco Small Cap Growth C | 1.75% |
FVUSA04AWV | JNL/Invesco Small Cap Growth I | 1.72% |
JGLYX | JPMorgan Small Cap Growth R4 | 1.50% |
QUARX | AB Small Cap Growth R | 1.45% |
RSEKX | Victory RS Small Cap Growth R | 1.33% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- TWST Tweets Stocktwits
Advertisement